EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes

Laurent Calvier iD, Catherine R Wasser, E Blair Solow, Sharon Wu, Bret M Evers, David S Karp, Maria Z Kounnas, Joachim Herz iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2418642122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Laurent Calvier und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Serine Endopeptidases, Nerve Tissue Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIDDK NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation, pannus formation, and progressive joint destruction. The inflammatory milieu in RA drives endothelial cell activation and upregulation of adhesion molecules, thus facilitating leukocyte infiltration into the synovium. Reelin, a circulating glycoprotein previously implicated in endothelial activation and leukocyte recruitment in diseases such as atherosclerosis and multiple sclerosis, has emerged as a potential upstream regulator of these processes. However, its role in RA pathogenesis remains poorly understood. Here, we demonstrate that Reelin levels are markedly elevated in the plasma of both RA patients and mouse models of arthritis, with higher concentrations correlating with greater disease severity. Genetic deletion of the Reelin receptor Apoer2 conferred significant protection against serum transfer arthritis (STA), underscoring the relevance of this pathway in disease progression. Furthermore, therapeutic inhibition of Reelin using the CR-50 antibody yielded robust anti-inflammatory effects in multiple preclinical arthritis models, including STA, K/BxN, and collagen-induced arthritis. Notably, CR-50 treatment not only reduced leukocyte infiltration and synovial inflammation but also mitigated pannus formation. Importantly, these benefits were achieved without the gastrointestinal side effects commonly associated with nonsteroidal anti-inflammatory drugs like diclofenac. Our findings position Reelin as a proinflammatory endothelial biomarker and therapeutic target in RA. By modulating endothelial activation and leukocyte recruitment, anti-Reelin strategies offer an alternative approach to attenuate synovial inflammation and joint damage. These results provide a compelling rationale for further exploration of Reelin-targeted therapies as alternatives to conventional immunosuppressive treatments in RA and other chronic inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsSerine EndopeptidasesNerve Tissue ProteinsSignal TransductionArthritis, RheumatoidLDL-Receptor Related ProteinsArthritis, ExperimentalReelin ProteinAnimalsMiceHumansMice, KnockoutInflammationFemaleMaleMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

arthritiscytokinesendothelial dysfunctioninflammationleukocytes

Substanzen

Reelin ProteinCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsSerine EndopeptidasesNerve Tissue ProteinsReln protein, mouseRELN protein, humanlow density lipoprotein receptor-related protein 8LDL-Receptor Related Proteins

Autor:innen und Institutionen

  • Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
  • O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
  • Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
  • Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
  • Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
  • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.

ORCID-Profile: Laurent Calvier, Joachim Herz

Förderung

  • NINDS NIH HHS
  • NIDDK NIH HHS
  • NIA NIH HHS
  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • See relevant section in the MS

Zitieren

APA

Calvier, L., Wasser, C. R., Solow, E. B., Wu, S., Evers, B. M., Karp, D. S., Kounnas, M. Z., & Herz, J. (2025). Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2418642122

Vancouver

Calvier L, Wasser CR, Solow EB, Wu S, Evers BM, Karp DS, et al. Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2418642122

BibTeX
@article{Calvier2025,
  author = {Calvier, Laurent and Wasser, Catherine R and Solow, E Blair and Wu, Sharon and Evers, Bret M and Karp, David S and Kounnas, Maria Z and Herz, Joachim},
  title = {Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2418642122}
}
Kostenlos starten →